PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11333262-6 2001 In a cell-free system, a fusion protein, p67N-p47N, had an 8-fold higher efficiency and produced a higher activity than the individual proteins, and also resulted in an 8-fold improved efficiency for Rac and a lowered K(m) for NADPH. NADP 227-232 AKT serine/threonine kinase 1 Homo sapiens 200-203 11705402-8 2001 The enzyme activity reconstituted with 67N-rac showed a 10-fold higher stability and a lower K(m) for NADPH than the individual components. NADP 102-107 AKT serine/threonine kinase 1 Homo sapiens 43-46 15123662-3 2004 We recently demonstrated that NADPH oxidase activation involves sequential interactions between Rac and the flavocytochrome b(558) and p67(phox) oxidase components to regulate electron transfer from NADPH to molecular oxygen. NADP 30-35 AKT serine/threonine kinase 1 Homo sapiens 96-99 7618083-4 1995 Native and recombinant PAKs phosphorylated the p47phox reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase component in a Rac-GTP-dependent manner. NADP 63-106 AKT serine/threonine kinase 1 Homo sapiens 138-141 8036496-2 1994 Upon stimulation of phagocytic cells, Rac enhances the activity of the enzyme nicotinamide adenine dinucleotide phosphate (reduced) (NADPH) oxidase, resulting in the production of superoxide radicals. NADP 78-121 AKT serine/threonine kinase 1 Homo sapiens 38-41 31729001-1 2020 The superoxide (O2 -)-generating NADPH oxidase complex of phagocytes comprises a membrane-associated heterodimeric flavocytochrome, known as cytochrome b 558 (consisting of NOX2 and p22phox) and four cytosolic regulatory proteins, p47phox, p67phox, p40phox, and the small GTPase Rac. NADP 34-39 AKT serine/threonine kinase 1 Homo sapiens 280-283 29669855-6 2018 SQLE increased the NADP+/NADPH (reduced form of NADP+) ratio, which triggered a cascade of events involving oxidative stress-induced DNA methyltransferase 3A (DNMT3A) expression, DNMT3A-mediated epigenetic silencing of PTEN, and activation of AKT-mTOR (mammalian target of rapamycin). NADP 19-24 AKT serine/threonine kinase 1 Homo sapiens 243-246 30846598-0 2019 Direct stimulation of NADP+ synthesis through Akt-mediated phosphorylation of NAD kinase. NADP 22-27 AKT serine/threonine kinase 1 Homo sapiens 46-49 30846598-2 2019 We find that growth factor signaling through the phosphoinositide 3-kinase (PI3K)-Akt pathway induces acute synthesis of NADP+ and NADPH. NADP 121-126 AKT serine/threonine kinase 1 Homo sapiens 82-85 30846598-2 2019 We find that growth factor signaling through the phosphoinositide 3-kinase (PI3K)-Akt pathway induces acute synthesis of NADP+ and NADPH. NADP 131-136 AKT serine/threonine kinase 1 Homo sapiens 82-85 30846598-3 2019 Akt phosphorylates NAD kinase (NADK), the sole cytosolic enzyme that catalyzes the synthesis of NADP+ from NAD+ (the oxidized form of NADH), on three serine residues (Ser44, Ser46, and Ser48) within an amino-terminal domain. NADP 96-101 AKT serine/threonine kinase 1 Homo sapiens 0-3 30846598-6 2019 These data indicate that Akt-mediated phosphorylation of NADK stimulates its activity to increase NADP+ production through relief of an autoinhibitory function inherent to its amino terminus. NADP 98-103 AKT serine/threonine kinase 1 Homo sapiens 25-28 29669855-6 2018 SQLE increased the NADP+/NADPH (reduced form of NADP+) ratio, which triggered a cascade of events involving oxidative stress-induced DNA methyltransferase 3A (DNMT3A) expression, DNMT3A-mediated epigenetic silencing of PTEN, and activation of AKT-mTOR (mammalian target of rapamycin). NADP 25-30 AKT serine/threonine kinase 1 Homo sapiens 243-246 21461238-5 2011 NAD(+) and NADP(+) activated protein kinase C and enhanced phosphorylation of mitogen-activated protein kinases and Akt. NADP 11-15 AKT serine/threonine kinase 1 Homo sapiens 116-119 24458280-0 2014 Akt is essential to induce NADPH-dependent NETosis and to switch the neutrophil death to apoptosis. NADP 27-32 AKT serine/threonine kinase 1 Homo sapiens 0-3 29231906-2 2017 Specifically, energy restriction in quiescent cells (ERiQ) through energetic perturbations causes adaptive changes in response to reduced ATP, NAD+ and NADP levels in a regulatory network spanned by AKT, NF-kappaB, p53 and mTOR. NADP 152-156 AKT serine/threonine kinase 1 Homo sapiens 199-202 21461238-6 2011 NAD(+)- and NADP(+)-mediated CCL2 release was significantly attenuated by SP6001250, U0126, LY294002, Akt inhibitor IV, RO318220, GF109203X, and diphenyleneiodium chloride. NADP 12-19 AKT serine/threonine kinase 1 Homo sapiens 102-105